Similar findings have been made in studies with nephropathy models where suppression of TGF-β and p-Smad2/3 expression (Xiao et al., 2009) or a decrease in Smad2 and an increase in inhibitory Smad7 (Hullett et al., 2005) have been detected. The gene discussed is SMAD2; the disease is kidney disorder.